Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Laresse
- Development stage
- Discontinued
- Lead developer
- FzioMed
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Intradermal
01
Overview
Laresse is a temporary dermal filler developed by FzioMed, a U.S.-based medical device company. It is composed of absorbable medical polymers, specifically carboxymethylcellulose (CMC) and polyethylene oxide (PEO). Classified as a medical device rather than a traditional pharmaceutical drug, Laresse is intended for the correction of facial soft tissue contour deficiencies, such as wrinkles and nasolabial folds. The product is non-bacterial, non-animal based, and not chemically cross-linked, which is intended to reduce the likelihood of allergic reactions. Although it received CE Mark approval and was launched in Europe in 2006, marketing and salesforce support were largely withdrawn by 2008.
- Brand names
- Laresse
Beyond the preview
Go deeper on Laresse.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laresse.